Related Experiment Video
Updated: May 17, 2026

Cecal Ligation Puncture Procedure
Published on: May 7, 2011
Pharmacological management of pediatric patients with sepsis
Marroyln L Simmons1, Spencer H Durham, Chenita W Carter
1Sacred Heart Hospital/Children's Hospital at Sacred Heart, 5151 N 9th Ave, Pensacola, FL 32304, USA. mlsimmons@shhpens.org
Insights
Sepsis is a leading cause of death in children globally. Prompt treatment with fluids, antibiotics, and supportive care improves outcomes, but further research is essential for pediatric sepsis management.
Area of Science:
- Pediatric critical care medicine
- Infectious diseases
- Emergency medicine
Background:
- Sepsis is a life-threatening condition with a significant mortality rate in children worldwide.
- Current guidelines emphasize rapid intervention, including fluid resuscitation and broad-spectrum antibiotics.
- Despite advancements, pediatric sepsis remains a critical public health challenge requiring ongoing research.
Purpose of the Study:
- To review the pathophysiology, treatment strategies, and supportive care for pediatric sepsis.
- To highlight the importance of timely and appropriate interventions based on current guidelines.
- To identify areas where further research is needed to improve pediatric sepsis outcomes.
Main Methods:
- Review of current literature and established guidelines for sepsis management.
- Discussion of key therapeutic components: fluid resuscitation, antibiotics, vasopressors, inotropes, and adjunctive therapies.
- Focus on the specific considerations for pediatric patients.
Main Results:
- Sepsis treatment involves a multi-faceted approach including rapid volume resuscitation and broad-spectrum antibiotics.
- De-escalation of antibiotics based on culture results is crucial.
- Vasopressors, inotropes, hydrocortisone, and insulin may be necessary for specific patient needs.
Conclusions:
- Adherence to current sepsis guidelines has improved outcomes but does not eliminate the need for further investigation.
- Optimizing pediatric sepsis management requires a comprehensive understanding of pathophysiology and tailored supportive care.
- Continued research is vital to refine treatment protocols and reduce mortality in pediatric sepsis.
Abstract:
With an overall mortality rate of 4.2%, sepsis is one of the most common causes of death in children worldwide. The Surviving Sepsis Campaign outlines rapid initiation of volume resuscitation with crystalloids and timely administration of broad-spectrum antibiotics as the backbone of sepsis treatment. Initial antibiotics should be broad enough to cover the most likely pathogens, but antibiotic therapy should be de-escalated when culture results become available. Therapy with a vasopressor and/or an inotrope is often necessary in patients with sepsis to improve blood pressure and cardiac output. Adjunctive therapy with hydrocortisone is sometimes beneficial in the setting of catecholamine resistance and/or adrenal insufficiency. Insulin may also be needed in some patients for the treatment of hyperglycemia. Current guidelines have improved the treatment of sepsis, but more research is needed. This article reviews sepsis pathophysiology, treatment, and supportive care specifically as they relate to pediatric patients.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Acute Pyelonephritis II: Diagnostic Studies and Management
